PLSE

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.01
Percentage change 0.07	%

Peers: CUTR IRTC NVRO ITGR IART ANIK NEO MDXG STER TMDX

| Held by: VTI IWM VXF IWO VTWO SCHA VHT VFMO IWC ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.97	Insider Own	81.28%	Shs Outstand	67.27M	Perf Week	-2.58%
Market Cap	1.02B	Forward P/E	-	EPS next Y	-	Insider Trans	-0.05%	Shs Float	12.60M	Perf Month	-15.41%
Enterprise Value	904.46M	PEG	-	EPS next Q	-	Inst Own	8.53%	Short Float	19.46%	Perf Quarter	-9.10%
Income	-60.24M	P/S	-	EPS this Y	-	Inst Trans	-4.54%	Short Ratio	13.09	Perf Half Y	-17.68%
Sales	0.00M	P/B	8.57	EPS next Y	-	ROA	-66.00%	Short Interest	2.45M	Perf YTD	-13.33%
Book/sh	1.76	P/C	8.51	EPS next 5Y	-	ROE	-77.86%	52W High	25.00 -39.64%	Perf Year	51.35%
Cash/sh	1.77	P/FCF	-	EPS past 3/5Y	26.13% 16.53%	ROIC	-47.96%	52W Low	10.52 43.44%	Perf 3Y	647.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.34% 5.17%	Perf 5Y	41.03%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-18.86%	Oper. Margin	-	ATR (14)	0.78	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.58	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.06	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.58	EPS Q/Q	-36.20%	SMA20	-5.92%	Beta	1.57	Target Price	5.00
Payout	-	Debt/Eq	0.07	Sales Q/Q	-	SMA50	-10.09%	Rel Volume	0.70	Prev Close	15.08
Employees	75	LT Debt/Eq	0.06	Earnings	May 08 AMC	SMA200	-14.49%	Avg Volume	187.35K	Price	15.09
IPO	May 18, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	131,879	Change	0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-27-21	Initiated	Stephens	Overweight	$28
Mar-11-21	Initiated	Maxim Group	Buy	$40
Jan-26-21	Reiterated	H.C. Wainwright	Buy	$16 → $40
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy	$6 → $16
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral	$26 → $6
Feb-25-19	Initiated	H.C. Wainwright	Buy	$27

May-23-25 04:05PM	Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-09-25 03:41AM	Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
May-08-25 04:05PM	Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results (Business Wire)
May-06-25 04:05PM	Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference (Business Wire)
May-01-25 07:00AM	Pulse Biosciences Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting (Business Wire)
04:05PM	Loading…
Apr-25-25 04:05PM	Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.06%
Apr-24-25 04:05PM	Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 (Business Wire) +6.00%
Apr-23-25 07:00AM	Pulse Biosciences Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting (Business Wire)
Apr-10-25 01:00PM	Pulse Biosciences: Some Key Questions Remain Unanswered (Seeking Alpha)
10:36AM	Pulse Biosciences: Interesting Product, But No Revenue Stream (Seeking Alpha)
Mar-28-25 08:10AM	Q4 2024 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +6.00%
03:03AM	Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs (GuruFocus.com)
Mar-27-25 07:46PM	Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:05PM	Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results (Business Wire)
Mar-26-25 04:05PM	Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference (Business Wire)
08:00AM	Loading…
Mar-07-25 08:00AM	Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 (Business Wire)
Mar-04-25 08:00AM	Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-20-25 04:05PM	Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-05-25 09:42AM	Pulse Biosciences names new CFO, continuing string of C-suite changes (MedTech Dive)
Feb-04-25 08:00AM	Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer (Business Wire) +14.84%
Jan-30-25 08:00AM	Pulse Biosciences Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting (Business Wire)
Jan-21-25 01:03PM	Pulse Biosciences touts positive results from PFA early feasibility study (Medical Device Network) +11.16%
07:00AM	Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360 Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium (Business Wire)
Jan-13-25 07:00AM	Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium (Business Wire)
Jan-10-25 08:00AM	Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer (Business Wire)
Jan-03-25 09:00AM	Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +10.34%
Dec-23-24 04:30PM	Pulse Biosciences, Inc. Announces Planned Redemption of Warrants (Business Wire) +5.34%
Dec-19-24 08:00AM	Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants (Business Wire)
Dec-17-24 08:00AM	Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery (Business Wire)
Oct-31-24 02:25PM	Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association (Business Wire)
01:58PM	Loading…
01:58PM	Q3 2024 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
05:01AM	Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Oct-30-24 04:05PM	Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results (Business Wire)
04:02PM	Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology (Business Wire)
Oct-21-24 08:00AM	Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024 (Business Wire)
Aug-21-24 07:55AM	Better Cotton Pakistan, PULSE to boost data transparency in cotton farming (Just Style) +13.76%
Aug-13-24 12:38PM	Q2 2024 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +8.05%
Aug-12-24 04:05PM	Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results (Business Wire)
04:01PM	Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors (Business Wire)
Aug-09-24 06:32AM	Pulse Biosciences launches first-in-human pulsed field ablation trial (Medical Device Network)
Aug-08-24 08:00AM	Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System (Business Wire) +9.74%
Aug-01-24 04:05PM	Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences (Business Wire)
Jul-29-24 04:05PM	Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024 (Business Wire) -11.36% -5.95%
Jul-09-24 07:27AM	Pulse drops 510(k) plan for PFA device after FDA requests clinical data (MedTech Dive)
06:53AM	Pulse Biosciences receives breakthrough device status for CellFX system (Medical Device Network)
Jul-08-24 08:00AM	Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation (Business Wire) +28.71%
Jul-03-24 02:44PM	Pulse Biosciences, Inc. Announces the Closing of its Rights Offering (Business Wire)
Jun-28-24 08:00AM	Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering (Business Wire)
Jun-04-24 08:00AM	Pulse Biosciences, Inc. Announces Commencement of Rights Offering (Business Wire)
May-20-24 05:39PM	Pulse Biosciences Moves New Record Date for Rights Offering (MT Newswires) +9.86% +13.40%
04:05PM	Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000 (Business Wire)
May-17-24 06:41AM	Pulse Biosciences names new CEO, reassigns former leader (MedTech Dive)
May-16-24 08:00AM	Pulse Biosciences CellFX Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting (Business Wire) +8.68%
May-14-24 05:17PM	Pulse Biosciences Appoints Burke Barrett as President, CEO (MT Newswires) +7.55% -5.59%
04:05PM	Pulse Biosciences Enhances Executive Leadership Team (Business Wire)
May-13-24 09:02AM	Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 08:00AM	Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System (Business Wire)
May-08-24 06:06AM	Q1 2024 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) -9.21%
03:56AM	Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-07-24 09:56PM	PLSE Stock Earnings: Pulse Biosciences Reported Results for Q1 2024 (InvestorPlace)
05:45PM	Pulse Biosciences Reports Q1 2024 Financial Results Amidst Strategic Business Developments (GuruFocus.com)
04:05PM	Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results (Business Wire)
May-02-24 08:00AM	Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000 (Business Wire) +5.92%
Apr-28-24 11:59AM	5 ChatGPT Penny Stock Picks Right Now (Insider Monkey)
Apr-24-24 04:05PM	Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024 (Business Wire)
Apr-01-24 04:19PM	Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.27%
Mar-29-24 06:30AM	Q4 2023 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 10:53PM	PLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023 (InvestorPlace) -8.27%
05:51PM	Pulse Biosciences Inc (PLSE) Reports Increased GAAP Costs and Narrowed Net Loss in 2023 (GuruFocus.com)
04:12PM	Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results (Business Wire)
04:10PM	Pulse Biosciences Announces Plans to Initiate a Rights Offering (Business Wire)
Mar-14-24 04:05PM	Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024 (Business Wire)
Mar-08-24 01:17PM	Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX nsPFA Percutaneous Electrode System (Business Wire)
Feb-14-24 08:00AM	Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX nsPFA 360 Cardiac Catheter First-in-Human Feasibility Study (Business Wire) +12.56%
Jan-31-24 08:00AM	Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium (Business Wire)
Jan-02-24 08:00AM	Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Cardiac Clamp (Business Wire) -9.97%
Dec-20-23 08:00AM	Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter (Business Wire) -7.11%
Nov-21-23 08:00AM	Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode (Business Wire) +5.59%
Nov-15-23 04:05PM	Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference (Business Wire) +9.62%
Nov-14-23 12:52PM	Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.58%
02:15AM	Q3 2023 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 11:13AM	Pulse Biosciences Inc (PLSE) Reports Decrease in Q3 Losses and Advances in Cardiac Device ... (GuruFocus.com)
08:00AM	Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results (Business Wire)
Nov-10-23 04:56PM	UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call (Business Wire) +11.57%
Oct-30-23 04:05PM	Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023 (Business Wire) +5.76%
Oct-24-23 08:00AM	Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery (Business Wire)
Oct-02-23 08:00AM	Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study (Business Wire)
Sep-29-23 08:00AM	Pulse Biosciences Nanosecond Pulsed Field Ablation (nsPFA) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit (Business Wire) -7.57%
Sep-27-23 08:00AM	Pulse Biosciences First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting (Business Wire)
Sep-07-23 04:05PM	Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase (Business Wire)
Aug-24-23 04:05PM	Pulse Biosciences Clarifies Details of Recent S-3 Filing (Business Wire) -8.95%
Aug-17-23 09:31AM	15 Best-Performing Stocks in the Last 12 Months (Insider Monkey)
Aug-11-23 06:28AM	Q2 2023 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +5.56%
Aug-10-23 04:05PM	Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results (Business Wire) -5.66%
Jul-30-23 09:35AM	Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have had a fantastic week as stock increased 31%, and they haven't stopped buying (Simply Wall St.)
Jul-27-23 04:05PM	Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023 (Business Wire) +25.61%
May-22-23 09:30AM	11 Stocks with Heavy Insider Buying in 2023 (Insider Monkey) -7.94%
May-18-23 07:00AM	Pulse Biosciences Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting (Business Wire) -5.73%
May-16-23 12:01PM	Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-12-23 07:43AM	Q1 2023 Pulse Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +6.31%

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
UECKER DARRIN	Chief Technology Officer	Jun 12 '25	Sale	16.40	15,000	246,000	137,872	Jun 16 08:23 PM
UECKER DARRIN	Chief Technology Officer	Jun 13 '25	Sale	15.98	15,000	239,700	122,872	Jun 16 08:23 PM
DARRIN UECKER	Officer	Jun 13 '25	Proposed Sale	15.98	15,000	239,740		Jun 13 04:14 PM
DARRIN UECKER	Officer	Jun 12 '25	Proposed Sale	16.40	15,000	246,048		Jun 12 04:25 PM
Barrett Burke Thomas	Former President and CEO	Dec 11 '24	Sale	17.42	50,000	871,000	63,172	Dec 20 05:00 PM
DUGGAN ROBERT W	Director	Dec 13 '24	Buy	17.18	55,256	949,298	42,328,717	Dec 17 08:02 PM
DUGGAN ROBERT W	Director	Dec 12 '24	Buy	17.13	45,404	777,771	42,273,461	Dec 17 06:05 AM
DUGGAN ROBERT W	Director	Dec 11 '24	Buy	17.35	56,054	972,344	42,228,057	Dec 13 07:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pulse Biosciences Inc

Upgrade your FINVIZ experience